Vol 2, No 5 (2010)
Mol Cell Pharmacol
Table of Contents
PharmSights
| Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 Inhibitor | Abstract PDF |
| Saisudha Koka, Rakesh C Kukreja | 173-178 |
Research Articles
| Over Expression of Nucleophosmin and Nucleolin Contributes to the Suboptimal Activation of a G2/M Checkpoint in Ataxia Telangiectasia Fibroblasts | Abstract PDF |
| Narasimharao Nalabothula, Devulapalli Chakravarty, Adam Pierce, France Carrier | 179-189 |
Reviews
| Epigenetic Reactivation of Estrogen Receptor: Promising Tools for Restoring Response to Endocrine Therapy | Abstract PDF |
| Neeraj K Saxena, Dipali Sharma | 191-202 |
| The Nucleolus Takes Control of Protein Trafficking Under Cellular Stress | Abstract PDF |
| Narasimharao Nalabothula, Fred E Indig, France Carrier | 203-212 |
| MicroRNA-based Cancer Therapeutics: Big Hope From Small RNAs | Abstract PDF |
| Arun Bhardwaj, Seema Singh, Ajay P Singh | 213-219 |
FDA Corner
| Gardasil Approved to Prevent Anal Cancer | Abstract PDF |
| 221 |
| FDA Approves New Treatment Option for Late-Stage Breast Cancer | Abstract PDF |
| 221-222 |
| FDA Approves Pradaxa to Prevent Stroke in People With Atrial Fibrillation | Abstract PDF |
| 222 |
| FDA Approves Botox to Treat Chronic Migraine | Abstract PDF |
| 222-223 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.